Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 30, 2015 2:55 PM ET


Company Overview of Enteris BioPharma, Inc.

Company Overview

Unigene Laboratories Inc., Peptelligence(TM) Drug Delivery Platform and Certain Assets comprises Peptelligence™ drug delivery, recombinant manufacturing platforms, and company’s Biotechnologies Strategic Business Unit. Peptelligence offers intellectual property covering drug delivery and manufacturing technologies, peptide research and development, and proprietary know-how.


United States

Key Executives for Enteris BioPharma, Inc.

President and Chief Financial Officer
Age: 51
Vice President of Business Development
Compensation as of Fiscal Year 2015.

Enteris BioPharma, Inc. Key Developments

Enteris BioPharma, Inc. Announces Board Changes

Enteris BioPharma, Inc. announced the appointment of Steven J. Brickner, Ph.D., Jonathan Chernoff, MD, Ph.D., and Waleed Danho, Ph.D to the company's Scientific Advisory Board. Dr. Brickner joins Enteris' Scientific Advisory Board as an expert in synthetic organic/medicinal chemistry and the discovery of novel antibacterial agents. Dr. Chernoff is an internationally recognized expert in signal transduction, with particular interest in the regulation of cell proliferation and movement by protein kinases and phosphatases. Currently the Chief Scientific Officer at the Fox Chase Cancer Center. Dr. Danho joins Enteris as one of the foremost leaders in the discovery of peptide-based drugs, peptide mimetics, and conformationally restricted peptides. Most recently the Distinguished Research Leader at Hoffmann-La Roche Inc.

Similar Private Companies By Industry

Company Name Region
EMD Serono, Inc. United States
Millennium Predictive Medicine, Inc. United States
Genovics United States
Epigenomics, Inc. United States
Blue Angel Holdings Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Enteris BioPharma, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at